![Otello Stampacchia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Otello Stampacchia
Directeur Général chez
OMEGA ALPHA SPAC
Fortune : 2 236 $ au 30/06/2026
Profil
Dr. Otello Stampacchia is an Independent Director at ImageneBio, Inc., a Chairman & Chief Executive Officer at Omega Alpha SPAC and a Founder & Managing Director at Omega Fund Management LLC.
He is on the Board of Directors at ImageneBio, Inc., Scorpion Therapeutics, Inc., Morphic Therapeutic, Inc., Amunix Pharmaceuticals, Inc., Photys Therapeutics, Inc. and Rectify Pharmaceuticals LLC.
Dr. Stampacchia was previously employed as an Independent Director by Ikena Oncology, Inc., an Independent Director by Morphic Holding, Inc., an Independent Director by Kronos Bio, Inc., an Independent Director by Gossamer Bio, Inc., an Independent Director by Replimune Group, Inc., an Associate by The Goldman Sachs Group, Inc., a Chairman by Aerium Therapeutics, Inc., a Partner & Head-Life Sciences by AlpInvest Partners BV, a Portfolio Manager by LODH Immunology Fund, and a Member-Supervisory Board by Micromet AG.
He also served on the board at ESSA Pharma, Inc., Trevi Therapeutics, Inc., MEDIAN Technologies SA, Micromet, Inc. /MD/, Trident Pharmaceuticals, Inc., Achaogen, Inc., Andrew Alliance SA, BioVex, Inc., CropDesign NV, DeveloGen AG, Exonhit, Intarcia Therapeutics, Inc., Juno Therapeutics, Inc., Kyntra Bio, Inc., Nuvation Bio Operating Co., Inc., Paratek Pharmaceuticals, Inc. /Old/, SpineVision SAS and Translate Bio, Inc. He received his graduate degree from the University of Pavia, a graduate degree from the University of Geneva and a doctorate degree from the University of Geneva.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0 % | 16/06/2026 | 379 ( 0 % ) | 2 236 $ | 30/06/2026 |
Postes actifs de Otello Stampacchia
| Sociétés | Poste | Début |
|---|---|---|
| OMEGA ALPHA SPAC | Directeur Général | 26/10/2020 |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Directeur/Membre du Conseil | - |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Directeur/Membre du Conseil | - |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Directeur/Membre du Conseil | 01/10/2020 |
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary bifunctional molecule therapeutics | Directeur/Membre du Conseil | - |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Fondateur | 01/01/2004 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Directeur/Membre du Conseil | 24/09/2018 |
Anciens postes connus de Otello Stampacchia
| Sociétés | Poste | Fin |
|---|---|---|
| KRONOS BIO, INC. | Directeur/Membre du Conseil | 31/03/2023 |
| REPLIMUNE GROUP, INC. | Directeur/Membre du Conseil | 26/01/2022 |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Otello Stampacchia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
37
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 37 |
|---|---|
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
SpineVision SAS
 SpineVision SAS Medical SpecialtiesHealth Technology Develops and markets implants for the treatment of spinal disorders | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
Trident Pharmaceuticals, Inc.
 Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel biologics for the treatment of autoimmune disorders | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
AlpInvest Partners BV
 AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners invests in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing in form of debt and equity for buyout, secondary and growth stage capital requirements and also makes co investments. | Finance |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops traits for cereal crops | Commercial Services |
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Health Technology |
MEDIAN Technologies SA
 MEDIAN Technologies SA Medical/Nursing ServicesHealth Services Engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology | Health Services |
University of Pavia
 University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
LODH Immunology Fund
 LODH Immunology Fund Investment ManagersFinance Venture Capital Fund | Finance |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Andrew Alliance SA
 Andrew Alliance SA Industrial MachineryProducer Manufacturing Develops and markets novel liquid handling robots to enhance the reproducibility and the efficiency of the pipetting process | Producer Manufacturing |
Ikena Oncology, Inc.
 Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Omega Alpha SPAC
 Omega Alpha SPAC Financial ConglomeratesFinance Operates as a blank check company | Finance |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | Commercial Services |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary bifunctional molecule therapeutics | Commercial Services |
Choisissez Zonebourse 
